Early discontinuation of empirical antibiotic treatment in neutropenic patients with acute myeloid leukaemia and high-risk myelodysplastic syndrome

INTRODUCTION: Current guidelines advocate empirical antibiotic treatment (EAT) in haematological patients with febrile neutropenia. However, the optimal duration of EAT is unknown. In 2011, we have introduced a protocol, promoting discontinuation of carbapenems as EAT after 3 days in most patients a...

Descripción completa

Detalles Bibliográficos
Autores principales: Niessen, F. A., van Mourik, M. S. M., Bruns, A. H. W., Raijmakers, R. A. P., de Groot, M. C. H., van der Bruggen, T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251665/
https://www.ncbi.nlm.nih.gov/pubmed/32460887
http://dx.doi.org/10.1186/s13756-020-00729-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251665/
https://www.ncbi.nlm.nih.gov/pubmed/32460887
http://dx.doi.org/10.1186/s13756-020-00729-2

Ejemplares similares